Literature DB >> 22472622

High-resolution structure of infectious prion protein: the final frontier.

Rodrigo Diaz-Espinoza1, Claudio Soto.   

Abstract

Prions are the proteinaceous infectious agents responsible for the transmission of prion diseases. The main or sole component of prions is the misfolded prion protein (PrP(Sc)), which is able to template the conversion of the host's natively folded form of the protein (PrP(C)). The detailed mechanism of prion replication and the high-resolution structure of PrP(Sc) are unknown. The currently available information on PrP(Sc) structure comes mostly from low-resolution biophysical techniques, which have resulted in quite divergent models. Recent advances in the production of infectious prions, using very pure recombinant protein, offer new hope for PrP(Sc) structural studies. This review highlights the importance of, challenges for and recent progress toward elucidating the elusive structure of PrP(Sc), arguably the major pending milestone to reach in understanding prions.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22472622      PMCID: PMC4049221          DOI: 10.1038/nsmb.2266

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  108 in total

1.  Formation of fibrous aggregates from a non-native intermediate: the isolated P22 tailspike beta-helix domain.

Authors:  B Schuler; R Rachel; R Seckler
Journal:  J Biol Chem       Date:  1999-06-25       Impact factor: 5.157

2.  Some clinical and histological observations on scrapie in sheep.

Authors:  A L DELEZ; D P GUSTAFSON; C N LUTTRELL
Journal:  J Am Vet Med Assoc       Date:  1957-11-15       Impact factor: 1.936

Review 3.  The hypothesis of the catalytic action of nucleic acid on the conversion of prion protein.

Authors:  Yraima Cordeiro; Jerson L Silva
Journal:  Protein Pept Lett       Date:  2005-04       Impact factor: 1.890

4.  Structure of the cross-beta spine of amyloid-like fibrils.

Authors:  Rebecca Nelson; Michael R Sawaya; Melinda Balbirnie; Anders Ø Madsen; Christian Riekel; Robert Grothe; David Eisenberg
Journal:  Nature       Date:  2005-06-09       Impact factor: 49.962

5.  Anchorless prion protein results in infectious amyloid disease without clinical scrapie.

Authors:  Bruce Chesebro; Matthew Trifilo; Richard Race; Kimberly Meade-White; Chao Teng; Rachel LaCasse; Lynne Raymond; Cynthia Favara; Gerald Baron; Suzette Priola; Byron Caughey; Eliezer Masliah; Michael Oldstone
Journal:  Science       Date:  2005-06-03       Impact factor: 47.728

6.  Biochemical and conformational variability of human prion strains in sporadic Creutzfeldt-Jakob disease.

Authors:  P Aucouturier; R J Kascsak; B Frangione; T Wisniewski
Journal:  Neurosci Lett       Date:  1999-10-15       Impact factor: 3.046

Review 7.  Variant Creutzfeldt-Jakob disease.

Authors:  J Collinge
Journal:  Lancet       Date:  1999-07-24       Impact factor: 79.321

8.  Prion protein of 106 residues creates an artifical transmission barrier for prion replication in transgenic mice.

Authors:  S Supattapone; P Bosque; T Muramoto; H Wille; C Aagaard; D Peretz; H O Nguyen; C Heinrich; M Torchia; J Safar; F E Cohen; S J DeArmond; S B Prusiner; M Scott
Journal:  Cell       Date:  1999-03-19       Impact factor: 41.582

9.  In vitro conversion of full-length mammalian prion protein produces amyloid form with physical properties of PrP(Sc).

Authors:  Olga V Bocharova; Leonid Breydo; Alexander S Parfenov; Vadim V Salnikov; Ilia V Baskakov
Journal:  J Mol Biol       Date:  2004-12-19       Impact factor: 5.469

10.  In vitro generation of infectious scrapie prions.

Authors:  Joaquín Castilla; Paula Saá; Claudio Hetz; Claudio Soto
Journal:  Cell       Date:  2005-04-22       Impact factor: 41.582

View more
  40 in total

1.  Multiple substitutions of methionine 129 in human prion protein reveal its importance in the amyloid fibrillation pathway.

Authors:  Sofie Nyström; Rajesh Mishra; Simone Hornemann; Adriano Aguzzi; K Peter R Nilsson; Per Hammarström
Journal:  J Biol Chem       Date:  2012-06-05       Impact factor: 5.157

2.  The extent of protease resistance of misfolded prion protein is highly dependent on the salt concentration.

Authors:  Luis Concha-Marambio; Rodrigo Diaz-Espinoza; Claudio Soto
Journal:  J Biol Chem       Date:  2013-12-12       Impact factor: 5.157

3.  Mammalian prion amyloid formation in bacteria.

Authors:  Bruno Macedo; Yraima Cordeiro; Salvador Ventura
Journal:  Prion       Date:  2016-03-03       Impact factor: 3.931

4.  Protein misfolding occurs by slow diffusion across multiple barriers in a rough energy landscape.

Authors:  Hao Yu; Derek R Dee; Xia Liu; Angela M Brigley; Iveta Sosova; Michael T Woodside
Journal:  Proc Natl Acad Sci U S A       Date:  2015-06-24       Impact factor: 11.205

5.  Determination of amyloid core structure using chemical shifts.

Authors:  Lukasz Skora; Markus Zweckstetter
Journal:  Protein Sci       Date:  2012-10-26       Impact factor: 6.725

6.  Single-molecule approaches to prion protein misfolding.

Authors:  Hao Yu; Derek R Dee; Michael T Woodside
Journal:  Prion       Date:  2013-01-28       Impact factor: 3.931

7.  Comparing the energy landscapes for native folding and aggregation of PrP.

Authors:  Derek R Dee; Michael T Woodside
Journal:  Prion       Date:  2016-05-03       Impact factor: 3.931

8.  Structural attributes of mammalian prion infectivity: Insights from studies with synthetic prions.

Authors:  Qiuye Li; Fei Wang; Xiangzhu Xiao; Chae Kim; Jen Bohon; Janna Kiselar; Jiri G Safar; Jiyan Ma; Witold K Surewicz
Journal:  J Biol Chem       Date:  2018-10-01       Impact factor: 5.157

9.  Helices 2 and 3 are the initiation sites in the PrP(C) → PrP(SC) transition.

Authors:  Jie Chen; D Thirumalai
Journal:  Biochemistry       Date:  2012-12-31       Impact factor: 3.162

10.  Attachment of pathogenic prion protein to model oxide surfaces.

Authors:  Kurt H Jacobson; Thomas R Kuech; Joel A Pedersen
Journal:  Environ Sci Technol       Date:  2013-05-30       Impact factor: 9.028

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.